# Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery

> **NCT04689048** · PHASE1 · RECRUITING · sponsor: **Baptist Health South Florida** · enrollment: 20 (estimated)

## Conditions studied

- Brain Metastases, Adult
- Brain Metastases
- Brain Cancer

## Interventions

- **DRUG:** 18F fluciclovine

## Key facts

- **NCT ID:** NCT04689048
- **Lead sponsor:** Baptist Health South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-04
- **Primary completion:** 2027-03
- **Final completion:** 2027-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04689048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04689048, "Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT04689048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*